{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T13:24:00Z","timestamp":1785936240449,"version":"3.56.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12974-017-0861-2","type":"journal-article","created":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T02:26:40Z","timestamp":1492655200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?"],"prefix":"10.1186","volume":"14","author":[{"given":"Patrizia","family":"Bossolasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Cancello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Doretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Silani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1504-1556","authenticated-orcid":false,"given":"Lidia","family":"Cova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,20]]},"reference":[{"key":"861_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cell.2014.12.019","volume":"160","author":"L Liu","year":"2015","unstructured":"Liu L, Zhang K, Sandoval H, Yamamoto S, Jaiswal M, Sanz E, et al. Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration. Cell. 2015;160:177\u201390.","journal-title":"Cell"},{"key":"861_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12974-016-0530-x","volume":"13","author":"A Parimisetty","year":"2016","unstructured":"Parimisetty A, Dorsemans A-C, Awada R, Ravanan P, Diotel N, Lefebvre d\u2019Hellencourt C. Secret talk between adipose tissue and central nervous system via secreted factors\u2014an emerging frontier in the neurodegenerative research. J Neuroinflammation. 2016;13:67.","journal-title":"J Neuroinflammation"},{"key":"861_CR3","first-page":"1887","volume":"2015","author":"Y Yang","year":"1852","unstructured":"Yang Y, Hu W, Jiang S, Wang B, Li Y, Fan C, et al. The emerging role of adiponectin in cerebrovascular and neurodegenerative diseases. Biochim Biophys Acta. 1852;2015:1887\u201394.","journal-title":"Biochim Biophys Acta"},{"key":"861_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.apsb.2012.06.008","volume":"2","author":"B Lee","year":"2012","unstructured":"Lee B, Shao J. Adiponectin and lipid metabolism in skeletal muscle. Acta Pharm Sin B. 2012;2:335\u201340.","journal-title":"Acta Pharm Sin B"},{"key":"861_CR5","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jaci.2007.10.018","volume":"121","author":"G Fantuzzi","year":"2008","unstructured":"Fantuzzi G. Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol. 2008;121:326\u201330.","journal-title":"J Allergy Clin Immunol"},{"key":"861_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jaac.2013.12.025","volume":"53","author":"N Weder","year":"2014","unstructured":"Weder N, Zhang H, Jensen K, Yang BZ, Simen A, Jackowski A, et al. Child abuse, depression, and methylation in genes involved with stress, neural plasticity, and brain circuitry. J Am Acad Child Adolesc Psychiatry. 2014;53:417\u201324.e5. Bowman G, editor.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"861_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/acn3.77","volume":"1","author":"K Sekiyama","year":"2014","unstructured":"Sekiyama K, Waragai M, Akatsu H, Sugama S, Takenouchi T, Takamatsu Y, et al. Disease-modifying effect of adiponectin in model of \u03b1-synucleinopathies. Ann Clin Transl Neurol. 2014;1:479\u201389.","journal-title":"Ann Clin Transl Neurol"},{"key":"861_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.bbi.2015.07.018","volume":"50","author":"J Chabry","year":"2015","unstructured":"Chabry J, Nicolas S, Cazareth J, Murris E, Guyon A, Glaichenhaus N, et al. Enriched environment decreases microglia and brain macrophages inflammatory phenotypes through adiponectin-dependent mechanisms: relevance to depressive-like behavior. Brain Behav Immun. 2015;50:275\u201387.","journal-title":"Brain Behav Immun"},{"key":"861_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bbrc.2014.02.077","volume":"446","author":"Z Wan","year":"2014","unstructured":"Wan Z, Mah D, Simtchouk S, Klegeris A, Little JP. Globular adiponectin induces a pro-inflammatory response in human astrocytic cells. Biochem Biophys Res Commun. 2014;446:37\u201342.","journal-title":"Biochem Biophys Res Commun"},{"key":"861_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2040-7378-2-15","volume":"2","author":"J Thundyil","year":"2010","unstructured":"Thundyil J, Tang S-C, Okun E, Shah K, Karamyan VT, Li Y-I, et al. Evidence that adiponectin receptor 1 activation exacerbates ischemic neuronal death. Exp Transl Stroke Med. 2010;2:15.","journal-title":"Exp Transl Stroke Med"},{"key":"861_CR11","doi-asserted-by":"publisher","first-page":"e1026","DOI":"10.1038\/cddis.2013.538","volume":"5","author":"SA Shah","year":"2014","unstructured":"Shah SA, Lee HY, Bressan RA, Yun DJ, Kim MO. Novel osmotin attenuates glutamate-induced synaptic dysfunction and neurodegeneration via the JNK\/PI3K\/Akt pathway in postnatal rat brain. Cell Death Dis. 2014;5:e1026.","journal-title":"Cell Death Dis"},{"key":"861_CR12","first-page":"5","volume":"4","author":"ST Ngo","year":"2015","unstructured":"Ngo ST, Steyn FJ. The interplay between metabolic homeostasis and neurodegeneration: insights into the neurometabolic nature of amyotrophic lateral sclerosis. Cell Regen (London, England). 2015;4:5.","journal-title":"Cell Regen (London, England)"},{"key":"861_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.tins.2014.05.006","volume":"37","author":"S Vucic","year":"2014","unstructured":"Vucic S, Rothstein JD, Kiernan MC. Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies. Trends Neurosci. 2014;37:433\u201342.","journal-title":"Trends Neurosci"},{"key":"861_CR14","doi-asserted-by":"publisher","first-page":"10812","DOI":"10.1073\/pnas.1308421110","volume":"110","author":"JC Dodge","year":"2013","unstructured":"Dodge JC, Treleaven CM, Fidler JA, Tamsett TJ, Bao C, Searles M, et al. Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis. Proc Natl Acad Sci U S A. 2013;110:10812\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"861_CR15","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s13311-014-0329-3","volume":"12","author":"KG Hooten","year":"2015","unstructured":"Hooten KG, Beers DR, Zhao W, Appel SH. Protective and toxic neuroinflammation in amyotrophic lateral sclerosis. Neurotherapeutics. 2015;12:364\u201375.","journal-title":"Neurotherapeutics"},{"key":"861_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.neuropharm.2014.12.023","volume":"96","author":"A Aguilar-Valles","year":"2015","unstructured":"Aguilar-Valles A, Inoue W, Rummel C, Luheshi GN. Obesity, adipokines and neuroinflammation. Neuropharmacology. 2015;96:124\u201334.","journal-title":"Neuropharmacology"},{"key":"861_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(10)70224-6","volume":"10","author":"L Dupuis","year":"2011","unstructured":"Dupuis L, Pradat P-F, Ludolph AC, Loeffler J-P. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011;10:75\u201382.","journal-title":"Lancet Neurol"},{"key":"861_CR18","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1159\/000446502","volume":"16","author":"ZA Ioannides","year":"2016","unstructured":"Ioannides ZA, Ngo ST, Henderson RD, McCombe PA, Steyn FJ. Altered metabolic homeostasis in amyotrophic lateral sclerosis: mechanisms of energy imbalance and contribution to disease progression. Neurodegener Dis. 2016;16:382\u201397.","journal-title":"Neurodegener Dis"},{"key":"861_CR19","doi-asserted-by":"publisher","first-page":"e71793","DOI":"10.1371\/journal.pone.0071793","volume":"8","author":"NR Stallings","year":"2013","unstructured":"Stallings NR, Puttaparthi K, Dowling KJ, Luther CM, Burns DK, Davis K, et al. TDP-43, an ALS linked protein, regulates fat deposition and glucose homeostasis. PLoS ONE. 2013;8:e71793. Planas J V., editor.","journal-title":"PLoS ONE"},{"key":"861_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1471-2377-13-84","volume":"13","author":"S K\u00f6rner","year":"2013","unstructured":"K\u00f6rner S, Hendricks M, Kollewe K, Zapf A, Dengler R, Silani V, et al. Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options. BMC Neurol. 2013;13:84.","journal-title":"BMC Neurol"},{"key":"861_CR21","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/ncpneuro0853","volume":"4","author":"P K\u00fchnlein","year":"2008","unstructured":"K\u00fchnlein P, Gdynia H-J, Sperfeld A-D, Lindner-Pfleghar B, Ludolph AC, Prosiegel M, et al. Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis. Nat Clin Pract Neurol. 2008;4:366\u201374.","journal-title":"Nat Clin Pract Neurol"},{"key":"861_CR22","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S1474-4422(15)00380-4","volume":"15","author":"RM Ahmed","year":"2016","unstructured":"Ahmed RM, Irish M, Piguet O, Halliday GM, Ittner LM, Farooqi S, et al. Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism. Lancet Neurol. 2016;15:332\u201342.","journal-title":"Lancet Neurol"},{"key":"861_CR23","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.molmed.2016.07.005","volume":"22","author":"JH Weishaupt","year":"2016","unstructured":"Weishaupt JH, Hyman T, Dikic I. Common molecular pathways in amyotrophic lateral sclerosis and frontotemporal dementia. Trends Mol Med. 2016;22:769\u201383.","journal-title":"Trends Mol Med"},{"key":"861_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293\u20139.","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"861_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3109\/21678421.2015.1049183","volume":"16","author":"A Ludolph","year":"2015","unstructured":"Ludolph A, Drory V, Hardiman O, Nakano I, Ravits J, Robberecht W, et al. A revision of the El Escorial criteria\u20142015. Amyotroph Lateral Scler Front Degener. 2015;16:291\u20132.","journal-title":"Amyotroph Lateral Scler Front Degener"},{"key":"861_CR26","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1001\/archneurol.2012.254","volume":"69","author":"J Costa","year":"2012","unstructured":"Costa J, Swash M, de Carvalho M. Awaji criteria for the diagnosis of amyotrophic lateral sclerosis: a systematic review. Arch Neurol. 2012;69:1410\u20136.","journal-title":"Arch Neurol"},{"key":"861_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/9781444341256.ch1","volume-title":"Introduction to neurodegeneration: the molecular pathology of dementia and movement disorders. Neurodegeneration: the molecular pathology of dementia and movement disorders","author":"DW Dickson","year":"2011","unstructured":"Dickson DW. Introduction to neurodegeneration: the molecular pathology of dementia and movement disorders. Neurodegeneration: the molecular pathology of dementia and movement disorders. Oxford: Wiley-Blackwell; 2011. p. 1\u20135."},{"key":"861_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2217\/dmt.14.30","volume":"4","author":"Y Matsuzawa","year":"2014","unstructured":"Matsuzawa Y. Obesity and metabolic syndrome: the contribution of visceral fat and adiponectin. Diabetes Manag. 2014;4:391\u2013401.","journal-title":"Diabetes Manag"},{"key":"861_CR29","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456\u201377.","journal-title":"Brain"},{"key":"861_CR30","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006\u201314.","journal-title":"Neurology"},{"key":"861_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/17482960802654364","volume":"10","author":"MJ Strong","year":"2009","unstructured":"Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:131\u201346.","journal-title":"Amyotroph Lateral Scler"},{"key":"861_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jns.2015.06.053","volume":"357","author":"ST Ngo","year":"2015","unstructured":"Ngo ST, Steyn FJ, Huang L, Mantovani S, Pfluger CMM, Woodruff TM, et al. Altered expression of metabolic proteins and adipokines in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2015;357:22\u20137.","journal-title":"J Neurol Sci"},{"key":"861_CR33","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/sj.ijo.0803427","volume":"31","author":"GA Laughlin","year":"2007","unstructured":"Laughlin GA, Barrett-Connor E, May S. Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones. Int J Obes (Lond). 2007;31:457\u201365.","journal-title":"Int J Obes (Lond)"},{"key":"861_CR34","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.genm.2010.11.010","volume":"7","author":"PA McCombe","year":"2010","unstructured":"McCombe PA, Henderson RD. Effects of gender in amyotrophic lateral sclerosis. Gend Med. 2010;7:557\u201370.","journal-title":"Gend Med"},{"key":"861_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/21678421.2013.865749","volume":"15","author":"P Bede","year":"2014","unstructured":"Bede P, Elamin M, Byrne S, Hardiman O. Sexual dimorphism in ALS: exploring gender-specific neuroimaging signatures. Amyotroph Lateral Scler Front Degener. 2014;15:235\u201343.","journal-title":"Amyotroph Lateral Scler Front Degener"},{"key":"861_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.nbd.2012.08.015","volume":"49","author":"AP Russell","year":"2013","unstructured":"Russell AP, Wada S, Vergani L, Hock MB, Lamon S, L\u00e9ger B, et al. Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis. Neurobiol Dis. 2013;49:107\u201317.","journal-title":"Neurobiol Dis"},{"key":"861_CR37","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1093\/hmg\/ddt202","volume":"22","author":"J Eschbach","year":"2013","unstructured":"Eschbach J, Schwalenstocker B, Soyal SM, Bayer H, Wiesner D, Akimoto C, et al. PGC-1 is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis. Hum Mol Genet. 2013;22:3477\u201384.","journal-title":"Hum Mol Genet"},{"key":"861_CR38","first-page":"373","volume":"5","author":"A Scafoglieri","year":"2014","unstructured":"Scafoglieri A, Clarys JP, Cattrysse E, Bautmans I. Use of anthropometry for the prediction of regional body tissue distribution in adults: benefits and limitations in clinical practice. Aging Dis. 2014;5:373\u201393.","journal-title":"Aging Dis"},{"issue":"4","key":"861_CR39","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","volume":"13","author":"W Chen","year":"2016","unstructured":"Chen W, Zhang X, Huang W. Role of neuroinflammation in neurodegenerative diseases (Review). Mol Med Rep. 2016;13(4):3391\u20136.","journal-title":"Mol Med Rep"},{"key":"861_CR40","doi-asserted-by":"publisher","first-page":"24493","DOI":"10.1038\/srep24493","volume":"6","author":"H Badshah","year":"2016","unstructured":"Badshah H, Ali T, Kim MO. Osmotin attenuates LPS-induced neuroinflammation and memory impairments via the TLR4\/NF\u03baB signaling pathway. Sci Rep. 2016;6:24493.","journal-title":"Sci Rep"},{"key":"861_CR41","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.2337\/db08-1750","volume":"58","author":"N Halberg","year":"2009","unstructured":"Halberg N, Schraw TD, Wang ZV, Kim J-Y, Yi J, Hamilton MP, et al. Systemic fate of the adipocyte-derived factor adiponectin. Diabetes. 2009;58:1961\u201370.","journal-title":"Diabetes"},{"key":"861_CR42","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/archneurol.2011.670","volume":"69","author":"TM Himbergen van","year":"2012","unstructured":"van Himbergen TM. Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and Alzheimer disease. Arch Neurol. 2012;69:594.","journal-title":"Arch Neurol"},{"key":"861_CR43","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/ene.12915","volume":"23","author":"K Kitagawa","year":"2016","unstructured":"Kitagawa K, Miwa K, Okazaki S, Sakaguchi M, Mochizuki H. Serum high-molecular-weight adiponectin level and incident dementia in patients with vascular risk factors. Eur J Neurol. 2016;23:641\u20137.","journal-title":"Eur J Neurol"},{"key":"861_CR44","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/j.1468-1331.2010.03194.x","volume":"18","author":"K Une","year":"2011","unstructured":"Une K, Takei YA, Tomita N, Asamura T, Ohrui T, Furukawa K, et al. Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer\u2019s disease. Eur J Neurol. 2011;18:1006\u20139.","journal-title":"Eur J Neurol"},{"key":"861_CR45","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.3233\/JAD-151116","volume":"52","author":"M Waragai","year":"2016","unstructured":"Waragai M, Adame A, Trinh I, Sekiyama K, Takamatsu Y, Une K, et al. Possible involvement of adiponectin, the anti-diabetes molecule, in the pathogenesis of Alzheimer\u2019s disease. J Alzheimers Dis. 2016;52:1453\u20139.","journal-title":"J Alzheimers Dis"},{"key":"861_CR46","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1212\/WNL.0000000000000445","volume":"82","author":"AM Nicholson","year":"2014","unstructured":"Nicholson AM, Finch NA, Thomas CS, Wojtas A, Rutherford NJ, Mielke MM, et al. Progranulin protein levels are differently regulated in plasma and CSF. Neurology. 2014;82:1871\u20138.","journal-title":"Neurology"},{"key":"861_CR47","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/archneurol.2011.670","volume":"69","author":"TM Himbergen van","year":"2012","unstructured":"van Himbergen TM, Beiser a S, Ai M, Seshadri S, Otokozawa S, Au R, et al. Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and Alzheimer disease: results from the Framingham Heart Study. Arch Neurol. 2012;69:594\u2013600.","journal-title":"Arch Neurol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-017-0861-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T06:07:16Z","timestamp":1569046036000},"score":1,"resource":{"primary":{"URL":"http:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-017-0861-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,20]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["861"],"URL":"https:\/\/doi.org\/10.1186\/s12974-017-0861-2","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,20]]},"article-number":"85"}}